Catalyst Wire Dossier Catalyst Wire Dossier

Low molecular weight heparin with soft-mist inhaler

low molecular weight heparin
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Low molecular weight heparin with soft-mist inhaler, covering 2021-08-05 to 2021-08-05. Get the full timeline:

Most recent: Clinical Trial Update: Effects of Low Molecular Weight Heparin Therapy With Soft-Mist Inhaler for COVID-19 Induced Hypoxemia [Phase 2, Phase 3]

See pricing